PATIENT-REPORTED ACTIVITY IMPAIRMENT, STRESS, AND TIREDNESS IMPROVEMENT IN PATIENTS WITH SEVERE, UNCONTROLLED ASTHMA WITH EOSINOPHILIC INFLAMMATION: POOLED RESULTS FROM TWO PHASE III TRIALS OF BENRALIZUMAB

Gopalan Gokul; OQuinn Sean; Xu Xiao; Hirsch Ian

首页> 外文期刊>Respirology : >PATIENT-REPORTED ACTIVITY IMPAIRMENT, STRESS, AND TIREDNESS IMPROVEMENT IN PATIENTS WITH SEVERE, UNCONTROLLED ASTHMA WITH EOSINOPHILIC INFLAMMATION: POOLED RESULTS FROM TWO PHASE III TRIALS OF BENRALIZUMAB

【24h】

PATIENT-REPORTED ACTIVITY IMPAIRMENT, STRESS, AND TIREDNESS IMPROVEMENT IN PATIENTS WITH SEVERE, UNCONTROLLED ASTHMA WITH EOSINOPHILIC INFLAMMATION: POOLED RESULTS FROM TWO PHASE III TRIALS OF BENRALIZUMAB

机译：患者报告的活动障碍，压力和疲劳，嗜酸性炎症严重，不受控制的哮喘的患者：来自Benralizumab的两期III试验的合并结果

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Respirology :》 |2017年第3期|共2页
作者
Gopalan Gokul; OQuinn Sean; Xu Xiao; Hirsch Ian;
展开▼
作者单位

AstraZeneca LP Gaithersburg MD USA;

AstraZeneca LP Gaithersburg MD USA;

AstraZeneca LP Gaithersburg MD USA;

AstraZeneca LP Gaithersburg MD USA;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类呼吸系及胸部疾病;
关键词

相似文献

外文文献
中文文献
专利

1. PATIENT-REPORTED ACTIVITY IMPAIRMENT, STRESS, AND TIREDNESS IMPROVEMENT IN PATIENTS WITH SEVERE, UNCONTROLLED ASTHMA WITH EOSINOPHILIC INFLAMMATION: POOLED RESULTS FROM TWO PHASE III TRIALS OF BENRALIZUMAB [J] . Gopalan Gokul, OQuinn Sean, Xu Xiao, Respirology : . 2017,第Suppla3期

机译：患者报告的活动障碍，压力和疲劳，嗜酸性炎症严重，不受控制的哮喘的患者：来自Benralizumab的两期III试验的合并结果
2. ASTHMA SYMPTOM IMPROVEMENTS WITH BENRALIZUMAB ARE ASSOCIATED WITH IMPROVEMENTS IN ACTIVITY FUNCTIONS AND QUALITY OF LIFE FOR PATIENTS WITH SEVERE, UNCONTROLLED ASTHMA: RESULTS OF POOLED PHASE III BENRALIZUMAB STUDIES [J] . Gopalan G., Xu X., OQuinn S., Thorax: The Journal of the British Thoracic Society . 2017,第Suppla3期

机译：哮喘症状改善与Benralizumab有关的是严重，不受控制的哮喘患者的活动功能和生活质量的改善：汇总阶段III的结果
3. Onset of Effect, Changes in Airflow Obstruction and Lung Volume, and Health-Related Quality of Life Improvements with Benralizumab for Patients with Severe Eosinophilic Asthma: Phase IIIb Randomized, Controlled Trial (SOLANA) [J] . Reynold A Panettieri Jr, Tobias Welte, Kartik V Shenoy, Journal of Asthma and Allergy . 2020,第3期

机译：效果，气流梗阻和肺部变化的变化，以及与Benralizumab对患有严重嗜酸性哮喘的患者的健康有关的生活质量改善：IIIB阶段随机，受控试验（索兰）
4. Daily patient-reported health status assessment improvements with benralizumab for patients with severe uncontrolled eosinophilic asthma [O] . Sean O’Quinn, Xiao Xu, Ian Hirsch 2019

机译：贝那利珠单抗对严重无法控制的嗜酸性粒细胞性哮喘患者的每日患者报告的健康状况评估改善
5. P68 Asthma symptom improvements with benralizumab are associated with improvements in activity functions and quality of life for patients with severe, uncontrolled asthma: results of pooled phase iii benralizumab studies [O] . G Gopalan, X Xu, S O’Quinn, 2017

机译：P68哮喘症状改善与Benralizumab有关的有关严重，不受控制的哮喘患者的活性功能和生活质量的改善：合并阶段III ZHALIZUMAB研究的结果

PATIENT-REPORTED ACTIVITY IMPAIRMENT, STRESS, AND TIREDNESS IMPROVEMENT IN PATIENTS WITH SEVERE, UNCONTROLLED ASTHMA WITH EOSINOPHILIC INFLAMMATION: POOLED RESULTS FROM TWO PHASE III TRIALS OF BENRALIZUMAB

著录项

相似文献

相关主题

期刊订阅